Akero Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Akero Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Akero Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 2.42K %, a 7.94% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.42K +178 +7.94% Sep 30, 2024
Q2 2024 2.59K +503 +24.1% Jun 30, 2024
Q1 2024 2.71K +1.26K +87.6% Mar 31, 2024
Q4 2023 2.48K +1.31K +113% Dec 31, 2023
Q3 2023 2.24K +1.31K +140% Sep 30, 2023
Q2 2023 2.09K +1.3K +165% Jun 30, 2023
Q1 2023 1.44K +503 +53.5% Mar 31, 2023
Q4 2022 1.17K -40.2 -3.34% Dec 31, 2022
Q3 2022 931 -626 -40.2% Sep 30, 2022
Q2 2022 787 -1.26K -61.6% Jun 30, 2022
Q1 2022 940 -1.12K -54.3% Mar 31, 2022
Q4 2021 1.21K -641 -34.7% Dec 31, 2021
Q3 2021 1.56K -128 -7.62% Sep 30, 2021
Q2 2021 2.05K +535 +35.3% Jun 30, 2021
Q1 2021 2.06K +72.4 +3.65% Mar 31, 2021
Q4 2020 1.85K Dec 31, 2020
Q3 2020 1.69K Sep 30, 2020
Q2 2020 1.52K Jun 30, 2020
Q1 2020 1.98K Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.